NA
GH icon

Navellier & Associates’s Guardant Health GH Stock Holding History

Navellier & Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
7,485
+2,231
+42% +$243K 0.09% 164
2026
Q1 		$485K Sell
5,254
-158
-3% -$15.9K 0.05% 217
2025
Q4 		$553K Sell
5,412
-2,342
-30% -$210K 0.06% 208
2025
Q3 		$484K Buy
+7,754
New +$422K 0.05% 262

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Navellier & Associates's GH Position: Q2 2026 in Review

Navellier & Associates increased its Guardant Health (GH) stake by 42% in Q2 2026, buying an estimated $243K and bringing the position to 7,485 shares worth $1.12M. The position accounts for 0.09% of the portfolio, ranked #164.

Navellier & Associates first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Navellier & Associates held 7,485 shares of Guardant Health worth $1.12M as of Q2 2026.
  • Navellier & Associates bought 2,231 Guardant Health shares in Q2 2026, an estimated $243K.
  • Guardant Health made up 0.09% of Navellier & Associates's portfolio in Q2 2026, its #164 holding.
  • Navellier & Associates first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.